|
Volumn 8, Issue 8, 2007, Pages 1035-1037
|
Managing multiple and extensively drug-resistant tuberculosis and HIV
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMINOSALICYLIC ACID;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
CAPREOMYCIN;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
KANAMYCIN;
PYRAZINAMIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
TERIZIDONE;
TUBERCULOSTATIC AGENT;
ANTIBIOTIC RESISTANCE;
DEVELOPING COUNTRY;
DISEASE SURVEILLANCE;
DRUG COST;
DRUG EFFICACY;
EDITORIAL;
EPIDEMIC;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
MULTIDRUG RESISTANCE;
RESOURCE MANAGEMENT;
SHORT COURSE THERAPY;
TREATMENT OUTCOME;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
ANTI-HIV AGENTS;
ANTITUBERCULAR AGENTS;
DEVELOPING COUNTRIES;
DIRECTLY OBSERVED THERAPY;
DISEASE OUTBREAKS;
DRUG RESISTANCE, BACTERIAL;
DRUG RESISTANCE, MULTIPLE;
HEALTH PERSONNEL;
HIV INFECTIONS;
HUMANS;
PREVALENCE;
TREATMENT OUTCOME;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
WORLD HEALTH;
|
EID: 34250626845
PISSN: 14656566
EISSN: None
Source Type: Journal
DOI: 10.1517/14656566.8.8.1035 Document Type: Editorial |
Times cited : (9)
|
References (6)
|